XM does not provide services to residents of the United States of America.

Climate change impeding fight against AIDS, TB and malaria



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Climate change impeding fight against AIDS, TB and malaria</title></head><body>

Adds quote and detail on TB final par, amends par 4

By Jennifer Rigby

LONDON, Sept 18 (Reuters) -Climate change and conflict are hitting efforts to tackle three of the world's deadliest infectious diseases, the head of the Global Fund to Fight AIDS, Tuberculosis and Malaria has warned.

International initiatives to fight the diseases have largely recovered after being badly affected by the COVID-19 pandemic, according to the Fund’s 2023 results report released on Monday.

But the increasing challenges of climate change and conflict mean the world is likely to miss the target of putting an end to AIDS, TB and malaria by 2030 without “extraordinary steps”, said Peter Sands, executive director of the Global Fund.

For example, malaria is spreading to highland parts of Africa that were previously too cold for the mosquito carrying the disease-causing parasite.

Extreme weather events like floods are overwhelming health services, displacing communities, causing upsurges in infection and interrupting treatment in many different places, the report said. In countries including Sudan, Ukraine, Afghanistan and Myanmar, simply reaching vulnerable communities has also been immensely challenging due to insecurity, it added.

There are positives, Sands said. For example, in 2022, 6.7 million people were treated for TB in the countries where the Global Fund invests, 1.4 million more people than in the previous year. The Fund also helped provide 24.5 million people with antiretroviral therapy for HIV, and distributed 220 million mosquito nets.

Sands added that innovative prevention and diagnostic tools also provided hope.

This week, there is a high-level meeting on TB at the UN General Assembly, and advocates hope for more of a focus on the disease.

The Global Fund has faced criticism from some TB experts for not allocating more of its budget to the disease, as it is the biggest killer of the three diseases the fund focuses on.

"There's no doubt that the world needs to devote more resources towards fighting TB... but it is not as simple as comparing annual deaths from each disease," said Sands. For example, he said, many countries with the highest burden of TB are middle-income countries that have more capacity to fund health services domestically.



Reporting by Jennifer Rigby; Editing by Jane Merriman and Edwina Gibbs

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.